Recombinant Chicken IL5RA
Cat.No. : | IL5RA-4581C |
Product Overview : | Recombinant Chicken IL5RA full length or partial length protein was expressed. |
- Specification
- Gene Information
- Related Products
Source : | Mammalian Cells |
Species : | Chicken |
Tag : | His |
Form : | Liquid or lyophilized powder |
Endotoxin : | < 1.0 eu per μg of the protein as determined by the LAL method. |
Purity : | >80% |
Notes : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Storage : | Store it at +4 oC for short term. For long term storage, store it at -20 oC~-80 oC. |
Storage Buffer : | PBS buffer |
Gene Name : | IL5RA interleukin 5 receptor, alpha [ Gallus gallus (chicken) ] |
Official Symbol : | IL5RA |
Gene ID : | 771801 |
Protein Refseq : | NP_001243081 |
UniProt ID : | G1UHB7 |
Products Types
◆ Recombinant Protein | ||
IL5RA-069H | Recombinant Human IL5RA Protein, C-His-tagged | +Inquiry |
Il5ra-1245M | Recombinant Mouse Il5ra Protein, MYC/DDK-tagged | +Inquiry |
IL5RA-366C | Recombinant Cynomolgus Monkey IL5RA Protein, His (Fc)-Avi-tagged | +Inquiry |
IL5RA-251H | Recombinant Human IL5RA Protein, MYC/DDK-tagged, C13 and N15-labeled | +Inquiry |
IL5RA-5176H | Recombinant Human IL5RA Protein | +Inquiry |
◆ Lysates | ||
IL5RA-001MCL | Recombinant Mouse IL5RA cell lysate | +Inquiry |
IL5RA-2060HCL | Recombinant Human IL5RA cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionRecombinant IL5RA can be used to treat IL5-related diseases, such as severe asthma and eosinophilic diseases. It can reduce the frequency and severity of asthma attacks by blocking the signaling of interleukin 5.
Currently, recombinant IL5RA is mainly used to treat IL5-related diseases, such as severe asthma and eosinophilic diseases. For other diseases, the suitability of IL5RA is subject to further research and clinical trials.
During the use of IL5RA, the doctor may ask to check the patient's blood routine regularly to monitor changes in blood counts and related indicators. This helps to evaluate the efficacy of the treatment and the safety of the patient.
There is no clear evidence that long-term use of recombinant IL5RA causes dependence. For patients using IL5RA, it is best to treat and discontinue the drug according to the advice and guidance of their doctor.
IL5RA is generally administered by subcutaneous injection. The specific use method and dosage should be determined according to the doctor's recommendation and the specific situation of the patient.
Common side effects of recombinant IL5RA include pain at the injection site, redness and swelling at the injection site, cough, and sore throat. A small number of patients may experience allergic reactions or serious adverse reactions, so close monitoring of the patient's condition and signs is required when using.
Customer Reviews (3)
Write a reviewGood stability under different temperature and humidity conditions.
In the process of purification, the removal of impurities is good.
Chemical modifications, such as PEGylation or glycosylation, have little effect.
Ask a Question for All IL5RA Products
Required fields are marked with *
My Review for All IL5RA Products
Required fields are marked with *
Inquiry Basket